These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17653509)

  • 1. Immediate effect of fluvastatin on lipid levels in acute coronary syndrome.
    Ostadal P; Alan D; Vejvoda J; Cepova J; Kukacka J; Blasko P; Martinkovicova L; Vojacek J
    Mol Cell Biochem; 2007 Dec; 306(1-2):19-23. PubMed ID: 17653509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
    Mendoza S; Gamez R; Mas R; Goicochea E
    Int J Tissue React; 2003; 25(3):81-9. PubMed ID: 14756189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
    Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate effect of intensive atorvastatin therapy on lipid parameters in patients with acute coronary syndrome.
    Vondrakova D; Ostadal P; Kruger A
    Lipids Health Dis; 2010 Jul; 9():71. PubMed ID: 20630099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d.
    Davidson MH; Palmisano J; Wilson H; Liss C; Dicklin MR
    Clin Ther; 2003 Nov; 25(11):2738-53. PubMed ID: 14693301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer HMG-CoA reductase inhibitor (statin) therapies.
    Brinton EA
    Clin Cardiol; 2001; 24(7 Suppl):II-10-3. PubMed ID: 11444648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fluvastatin, a new inhibitor of HMG-CoA reductase, and niceritrol on serum lipids, lipoproteins and cholesterol ester transfer activity in primary hypercholesterolemic patients.
    Sasaki J; Yamamoto K; Kobori S; Setoguchi Y; Sato Y; Matsunaga A; Shichiri M; Sakai T; Kono S; Arakawa K
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):420-6. PubMed ID: 7582401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of combined hyperlipidemia with fluvastatin and gemfibrozil, alone or in combination, does not induce muscle damage.
    Smit JW; Jansen GH; de Bruin TW; Erkelens DW
    Am J Cardiol; 1995 Jul; 76(2):126A-128A. PubMed ID: 7604787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined treatment of hypercholesterolemia of renal transplant allograft recipients with fluvastatin and gemfibrozil.
    Vergoulas G; Miserlis G; Solonaki F; Imvrios G; Gakis D; Papanikolaou V; Papagiannis A; Visvardis G; Takoudas D; Antoniadis A
    Transpl Int; 2000; 13 Suppl 1():S64-7. PubMed ID: 11111964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial.
    Holdaas H; Jardine AG; Wheeler DC; Brekke IB; Conlon PJ; Fellstrøm B; Hammad A; Holme I; Isoniemi H; Moore R; Rowe PA; Sweny P; Talbot DA; Wadstrøm J; Østraat Ø
    Kidney Int; 2001 Nov; 60(5):1990-7. PubMed ID: 11703619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-lowering effects of fluvastatin in renal transplant patients. A clinical observation.
    Lal SM; Gupta N; Georgiev O; Ross G
    Int J Artif Organs; 1997 Jan; 20(1):18-21. PubMed ID: 9062827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluvastatin as co-medication in heart transplant recipients with elevated creatine-kinase.
    Sadoni S; Kaczmarek I; Delgado O; Schmöckel M; Reichart B; Meiser B
    Transplant Proc; 2007 Mar; 39(2):558-9. PubMed ID: 17362781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of lipid levels and lipid-lowering therapy on restenosis after coronary artery stenting.
    Lerakis S; El-Chami MF; Patel AD; Veledar E; Alexopoulos E; Zacharoulis A; Triantafyllou A
    Am J Med Sci; 2006 May; 331(5):270-3. PubMed ID: 16702797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alcohol consumption on pharmacokinetics, efficacy, and safety of fluvastatin.
    Smit JW; Wijnne HJ; Schobben F; Sitsen A; de Bruin TW; Erkelens DW
    Am J Cardiol; 1995 Jul; 76(2):89A-96A. PubMed ID: 7604808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin therapy and low-density lipoprotein cholesterol reduction in HIV-infected individuals after acute coronary syndrome: Results from the PACS-HIV lipids substudy.
    Boccara F; Miantezila Basilua J; Mary-Krause M; Lang S; Teiger E; Steg PG; Funck-Brentano C; Girard PM; Costagliola D; Cohen A; Guiguet M;
    Am Heart J; 2017 Jan; 183():91-101. PubMed ID: 27979047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of a combination of fluvastatin and bezafibrate in patients with mixed hyperlipidaemia (FACT study).
    Pauciullo P; Borgnino C; Paoletti R; Mariani M; Mancini M
    Atherosclerosis; 2000 Jun; 150(2):429-36. PubMed ID: 10856536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum lipid comparison in patients treated by statins or fibrates: existence of bad HDL-C responders to statins.
    Devroey D; Velkeniers B; Duquet W; Betz W
    Acta Cardiol; 2003 Jun; 58(3):179-84. PubMed ID: 12846506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
    Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting triglycerides predict recurrent ischemic events in patients with acute coronary syndrome treated with statins.
    Schwartz GG; Abt M; Bao W; DeMicco D; Kallend D; Miller M; Mundl H; Olsson AG
    J Am Coll Cardiol; 2015 Jun; 65(21):2267-75. PubMed ID: 26022813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.